清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The use of PARP inhibitors as single agents and as chemosensitizers in sporadic pancreatic cancer.

软膜 吉西他滨 奥拉帕尼 PARP抑制剂 顺铂 医学 胰腺癌 癌症研究 癌症 聚ADP核糖聚合酶 肿瘤科 内科学 化疗 生物 聚合酶 基因 生物化学
作者
J. A. De Soto,Randy Mullins
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:29 (15_suppl): e13542-e13542 被引量:8
标识
DOI:10.1200/jco.2011.29.15_suppl.e13542
摘要

e13542 Background: Introduction: After resection of pancreatic cancer local recurrence occurs in 50%-80% of the cases while distant metastasis develops 75% of the time. Most pancreatic cancers have impairments of DNA repair. PARP inhibitors may further inhibit the ability fo the cancer to undergo DNA repair. Current, adjuvant therapy often consist of gemcitabine, cisplatin and/or 5-fluorouracil which add a modest increase in median survival by 4-5 months. In this study, we treated human pancreatic cancer cells with poly(ADP-ribose) polymerase (PARP) Inhibitors (AG14361, veliparib and olaparib) alone or with gemcitabine, cisplatin or 5-fluorouracil. Methods: CFPAC-1 and BXPC-3 , HPAC human pancreatic cancer cell lines were treated for 72 hours with PARP inhibitors alone or in combination with gemcitabine, cisplatin, or 5-fluorouracil. Validated MTT assays were used to form dose response curves from which the IC50 values were calculated. PARP activity was measured indirectly through PAR levels and correlated with the IC50 values of PARP inhibition of each cell line. Results: The PARP1 IC50 values for CFPAC-1, BXPC-3 and HPAC pancreatic cancer cell lines were AG14361 (14.3 µM, 12.7 µM, 38.3 µM ), veliparib (52.6 µM, 100.9 µM 102.0 µM ) and olaparib (79.5 µM, 184.8 µM, 200.2 µM) .These values indicate a sensitivity to PARP1 inhibitors of pancreatic cancer cell lines that is at least as great as the sensitivity of ovarian and breast cancer cell lines to PARP1 inhibition. The IC50 values of cisplatin, were decreased up to 60 fold in the presence of clinically relevant amounts of PARP inhibitor while 5-fluorouracil IC50 values were decreased up to 6000 fold in the presence of clinically relevant amounts of PARP inhibitor. Gemcitabine was inhibited up to 73% by PARP inhibitors. The was poor correlation between PARP activity and teh ability of PARP inhibitors to inhibit pancreatic cancer growth. Conclusions: Sporadic pancreatic cancer cells are exquisitely sensitive to PARP inhibition. PARP inhibitors significantly enhanced the cytotoxicity of cisplatin and 5-fluorouracil while inhibiting gemcitabine. There is little correlation between endogenous PARP activity and the effectiveness of PARP inhibitors to inhibit cancer growth.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
gmail完成签到,获得积分10
3秒前
4秒前
ZF完成签到,获得积分10
4秒前
看到催我读文献完成签到,获得积分10
4秒前
Hdx完成签到,获得积分10
5秒前
紧张的幼蓉完成签到,获得积分10
6秒前
benyia完成签到,获得积分10
7秒前
可靠的靖巧完成签到,获得积分10
7秒前
爱学习完成签到,获得积分10
8秒前
spicyfish完成签到,获得积分10
9秒前
开朗的晋鹏完成签到,获得积分10
10秒前
笑傲完成签到,获得积分10
17秒前
19秒前
小蘑菇的应助被阿俊采纳,获得10
25秒前
无奈小玉完成签到,获得积分10
26秒前
27秒前
stonezcl完成签到,获得积分10
29秒前
我要吃饭了完成签到 ,获得积分10
31秒前
陵墨完成签到,获得积分10
32秒前
小巧的绮完成签到,获得积分10
38秒前
呆萌尔风完成签到,获得积分10
38秒前
莫忘初心完成签到,获得积分10
42秒前
典雅思真完成签到,获得积分10
42秒前
wrxaa完成签到,获得积分10
44秒前
整齐的开山完成签到,获得积分10
44秒前
benlaron完成签到,获得积分10
47秒前
花开富贵完成签到,获得积分10
47秒前
快乐舒完成签到 ,获得积分10
49秒前
MaidLingYan完成签到,获得积分10
49秒前
独特的又菱完成签到,获得积分10
49秒前
ybcy完成签到,获得积分10
49秒前
ln完成签到,获得积分10
50秒前
聪明的羿完成签到,获得积分10
50秒前
50秒前
大力的映天完成签到,获得积分10
51秒前
Zilaap完成签到,获得积分10
53秒前
爱栗子完成签到,获得积分10
53秒前
忧郁凝阳完成签到,获得积分10
54秒前
CaptainMus完成签到,获得积分10
54秒前
内向的镜子完成签到,获得积分10
55秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179980
求助须知:如何正确求助?哪些是违规求助? 9570196
关于积分的说明 21808504
捐赠科研通 7775913
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557383
邀请新用户注册赠送积分活动 2478998